Showing results (131-140 of 153) with videos related to
Sort By:
Pageof 16
The Journal of Urology|March 7, 2006
Prostate specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trialE David Crawford, Paul F Pinsky, David Chia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion UpdateJessica P Hwang, Mark R Somerfield, Devena E Alston-Johnson, et al.Journal of the National Cancer Institute|May 15, 2008
Design and endpoints of clinical trials in hepatocellular carcinomaJosep M Llovet, Adrian M Di Bisceglie, Jordi Bruix, et al.Statistics in Medicine|May 15, 2014
How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes throughStuart G Baker, Ewoud Schuit, Ewout W Steyerberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Cancer Care Delivery Research: Building the Evidence Base to Support Practice Change in Community OncologyErin E Kent, Sandra A Mitchell, Kathleen M Castro, et al.The Journal of Urology|March 3, 2009
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2009
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reductionKala Visvanathan, Rowan T Chlebowski, Patricia Hurley, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 8, 2014
Future directions for postdoctoral training in cancer prevention: insights from a panel of expertsDavid E Nelson, Jessica Faupel-Badger, Siobhan Phillips, et al.Journal of the National Cancer Institute|March 17, 2005
Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trialGerald L Andriole, David L Levin, E David Crawford, et al.Pageof 16